The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R von Gross, David J, Munter, Gabriel, Bitan, Menachem, Siegal, Tali, Gabizon, Alberto, Weitzen, Ronny, Merimsky, Ofer, Ackerstein, Aliza, Salmon, Asher, Sella, Avishai, Slavin, Shimon

Volltext